Skip to main content
Equibles

UBS Group AG

Position in CRMD — CorMedix Inc.

CIK 1610520 ZURICH, V8
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,741,828
+$4,297,146 QoQ
Shares Held
1,877,940
+22.1% QoQ
Ownership
2.41%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 194 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. CRMD ranks #97 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CRMD

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,741,828 1,877,940
2026-03-31 $10,444,682 1,538,245
2025-12-31 $7,397,085 636,035
2025-09-30 $12,687,259 1,090,908
2025-06-30 $3,399,629 275,944
2025-03-31 $3,711,609 602,534
2024-12-31 $3,076,930 379,868
2024-09-30 $319,288 39,516
2024-06-30 $159,424 36,819
2024-03-31 $262,464 61,902
2023-12-31 $242,041 64,373
2023-09-30 $114,636 30,983
2023-06-30 $163,753 41,248
2022-12-31 $3,920 929
2022-09-30 $21,624 7,641
2022-03-31 $55,889 10,199
2021-12-31 $83,300 18,308
2021-09-30 $21,970 4,725
2021-06-30 $6,688 975
2021-03-31 $96,643 9,674
2020-12-31 $54,298 7,308
2020-09-30 $24,258 4,023
2020-06-30 $63,182 10,029
2020-03-31 $55,088 15,345